Couple-based Intervention on Quality of Life in HIV Male Serodiscordant Couples
Launched by CITY UNIVERSITY OF HONG KONG · Jul 11, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a couple-based program can improve the quality of life and relationship satisfaction for male couples where one partner is HIV positive and the other is HIV negative. The researchers believe that this type of intervention will be more helpful than standard care. Couples in the trial will participate in three sessions designed to strengthen their relationship and support each other, while those in the control group will receive usual care without the additional support.
To be eligible for this study, both partners must be male, over 18 years old, and have been in a relationship for at least three months. One partner needs to be HIV positive, and the other must be HIV negative. It's important that both partners are willing to participate. This study is currently recruiting participants, and it aims to understand not just the effectiveness of the intervention, but also how well it is received and whether it fits into the lives of the couples involved.
Gender
MALE
Eligibility criteria
- • The inclusion criteria for couples will be: (a) both partners are males, (b) both partners age over 18, (c) both partners report being a couple for at least three months, (d) one partner is HIV positive and the other partner is HIV-negative (i.e., serodiscordant couples), and (e) both partners are willing to participate.
- • The exclusion criteria for couples will be: (a) either partner cannot complete the assessment due to a low education level or physical or psychological constraint, and (b) either partner has been diagnosed with another life-threatening disease (e.g., cancer).
About City University Of Hong Kong
City University of Hong Kong is a leading academic institution dedicated to advancing knowledge and promoting innovative research in various fields, including healthcare and clinical studies. With a commitment to excellence in education and research, the university actively engages in clinical trials aimed at addressing critical health challenges and improving patient outcomes. Leveraging its multidisciplinary expertise and state-of-the-art facilities, City University of Hong Kong collaborates with healthcare professionals and industry partners to facilitate cutting-edge research that translates into real-world applications, fostering a healthier future for communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chengdu, , China
Guangzhou, , China
Shenzhen, , China
Xiamen, , China
Patients applied
Trial Officials
Nancy Xiaonan Yu, PhD
Principal Investigator
City University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported